Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average – Should You Sell?

Pro-Dex, Inc. (NASDAQ:PDEX) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $37.86 and traded as high as $49.75. Pro-Dex shares last traded at $49.00, with a volume of 16,904 shares.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Pro-Dex in a research report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Pro-Dex presently has an average rating of “Moderate Buy” and a consensus target price of $56.00.

Pro-Dex Stock Performance

The business’s fifty day moving average price is $42.50 and its 200-day moving average price is $37.86. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.03 and a quick ratio of 2.25. The stock has a market capitalization of $149.39 million, a PE ratio of 13.69 and a beta of -0.04.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings data on Thursday, January 29th. The medical instruments supplier reported $0.66 EPS for the quarter, beating the consensus estimate of $0.59 by $0.07. The company had revenue of $18.66 million during the quarter, compared to analysts’ expectations of $17.30 million. Pro-Dex had a net margin of 15.73% and a return on equity of 22.53%. As a group, equities research analysts expect that Pro-Dex, Inc. will post 2 EPS for the current year.

Hedge Funds Weigh In On Pro-Dex

A number of institutional investors have recently added to or reduced their stakes in the business. Police & Firemen s Retirement System of New Jersey bought a new stake in shares of Pro-Dex during the 2nd quarter valued at about $28,000. Los Angeles Capital Management LLC bought a new position in shares of Pro-Dex in the fourth quarter worth approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Pro-Dex in the second quarter worth approximately $50,000. AlphaQuest LLC purchased a new stake in Pro-Dex in the third quarter valued at approximately $71,000. Finally, Bank of America Corp DE raised its stake in Pro-Dex by 173.3% in the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock valued at $74,000 after purchasing an additional 1,073 shares in the last quarter. 15.28% of the stock is currently owned by institutional investors.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.